XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
  Hypertension
  CAD
  Myocardial Infarction
  CHF
  Clinical Trials
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

American Heart Journal

CAD Channel
subscribe to CAD newsletter

Latest Research : Cardiology : CAD

   DISCUSS   |   EMAIL   |   PRINT
Framingham score underestimates the risk of developing coronary heart disease in women
Dec 20, 2005, 00:24, Reviewed by: Dr. Rashmi Yadav

"We wanted to verify if the Framingham score truly captured who was most at risk, but it turns out to have underestimated a large number of those who should be considered for preventive therapies."

 
Traditional risk-factor scoring fails to identify approximately one-third of women likely to develop coronary heart disease (CHD), the leading cause of death of women in the United States, according to a pair of reports from cardiologists at Johns Hopkins.

"Our best means of preventing coronary heart disease is to identify those most likely to develop the condition, and intervene with lifestyle changes and drug treatment before symptoms start to appear," says the senior author of both studies, cardiologist Roger Blumenthal, M.D., an associate professor and director of the Ciccarone Preventive Cardiology Center at The Johns Hopkins University School of Medicine and its Heart Institute. "The goal is to strongly consider therapies, such as aspirin, cholesterol-lowering medications and, possibly, blood pressure medications for individuals at higher risk, so that heart attacks will be less likely to occur in the future."

The Hopkins findings, the latest of which appear in the American Heart Journal online Dec. 16, is believed to be one of the first critical assessments of the Framingham Risk Estimate (FRE) as the principal test for early detection of heart disease. The researchers wanted to determine why many of these women at risk for heart disease are not identified earlier.

The FRE is a total estimate of how likely a person is to suffer a fatal or nonfatal heart attack within 10 years, and it is based on a summary estimate of major risk factors for coronary heart disease, such as age, blood pressure, blood cholesterol levels and smoking.

However, Blumenthal says, many women with cardiovascular problems go undetected despite use of the Framingham score. While the death rate for men from cardiovascular disease has steadily declined over the last 20 years, the rate has remained relatively the same for women, he says.

In their latest report, the Hopkins researchers examined the risk of premature CHD in women whose average age was 50 and who were participating in the Sibling and Family Heart Study, a long-term study of how heart disease develops among family members. Study subjects had no symptoms of heart disease, but had a sibling who had been hospitalized for a coronary event, such as a heart attack before age 60.

The researchers calculated each woman's Framingham score and found that 98 percent were gauged to be at very low risk for future CHD, with an FRE of less than 6 percent, while only 2 percent of participants were judged to be at intermediate risk for future CHD, with an FRE between 10 percent and 20 percent.

When the results were contrasted with evidence gleaned from CT-scan measurements of calcium build-up in the arteries, the researchers found that one-third of women originally classified as very low risk actually had coronary atherosclerosis, a hardening and narrowing of the arteries that can lead to heart attacks if not controlled with drug therapy along with diet, exercise and other lifestyle changes. Indeed, 12 percent of women in the study had advanced stages of atherosclerosis, while another 6 percent had severe calcium build-up.

"We wanted to verify if the Framingham score truly captured who was most at risk, but it turns out to have underestimated a large number of those who should be considered for preventive therapies," says Blumenthal.

According to the researchers, performing cardiac CT scans on everyone with a low Framingham score is not a practical option for improving upon traditional risk-factor screening. To better determine who should get scanned, even if they have a low risk assessment, the Hopkins team began to search for additional predictors of who was most at risk. They found that people with two or more risk factors, such as obesity, smoking or metabolic syndrome, plus a family history for heart disease were those most likely to have a high calcium score. It is this group, the researchers say, who should be considered for a fast cardiac CT scan regardless of low Framingham scores and if the physician or patient is unsure about the need to go on long-term preventive therapies.

In a related, second investigation, published online in the May edition of the journal Atherosclerosis, the Hopkins team analyzed the Framingham scores of 2,447 women age 45 to 65, all of whom were participating in another long-term study in Ohio of adults referred by a physician for a cardiac risk assessment.

Again, when the FRE results were compared to calcium scores, 84 percent (408 of 489) of those classified as low risk by FRE actually had some coronary atherosclerosis. Twenty percent of those who were classified at intermediate risk by FRE had signs of advanced atherosclerosis.

"Our results show that if a CT scan had not been performed in addition to traditional risk-factor scoring, a large number of women would have missed the chance to begin preventive therapies," says cardiologist Erin Michos, M.D., a clinical research fellow at Hopkins and its Heart Institute. Michos led both Hopkins studies.

"For some women, especially those with a family history of heart disease and multiple risk factors for it, additional screening using CT scan and calcium scoring may be warranted," she adds.
 

- The Hopkins findings appear in the latest of which appear in the American Heart Journal online Dec. 16
 

www.hopkinsmedicine.org

 
Subscribe to CAD Newsletter
E-mail Address:

 

Funding for these studies, whose data analyses took place between January 2003 and November 2004, was provided by the National Institutes of Health, including the National Institute of Nursing Research and the National Heart, Lung and Blood Institute, the Johns Hopkins General Clinical Research Center and the Maryland Athletic Club Charitable Foundation.

Other researchers involved in the two studies were Khurram Nasir, M.D., M.B.A.; Joel Braunstein, M.D.; John Rumberger, M.D.; Matthew Budoff, M.D.; Wendy Post, M.D.; Chandra Vasamreddy, M.D.; Diane Becker, M.P.H., Sc.D.; Lisa Yanek, M.P.H.; Taryn Moy, M.S.; Elliot Fishman, M.D.; and Lewis Becker, M.D.

*New RSS Feed available from Johns Hopkins Medicine: http://www.hopkinsmedicine.org/mediaII/RSSinstructions.html
Contact: Gary Stephenson

410-955-5384
Johns Hopkins Medical Institutions


Related CAD News

Genetic Regulator for Coronary Artery Smooth Muscle Cells Identified
New Risk Factors Do Not Improve Assessment Of Coronary Heart Disease Risk
Angioplasty: door-to-balloon time matters regardless of time to presentation
ESC Updated Guidelines for Stable Angina Pectoris Management
Antioxidant Selenium Offers No Heart-Disease Protection
Coffee not linked with coronary heart disease
Adding abciximab to the antithrombotic regimen significantly reduces post-stent complications
Stenting just the left main stem gives equivalent results
Serotonin may play role in hardening of the arteries
Severe Heart Disease, Poor Prognosis Linked To Erectile Dysfunction


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us